Discusses three major classes of asthma therapies-bronchodilators,
antiinflammatories, and antiallergics-as well as potential new therapeutic
approaches
This comprehensive volume addresses the latest treatment strategies for asthma,
keying in on the genetics and molecular biology of asthma and pointing the way
toward new, commercially viable therapies.
Presents the most up-to-date information available on the genetics,
epidemiology, pathology, pharmacology, and pulmonology of asthma.
Written by more than 20 leading international experts, New and Exploratory
Therapeutic Agents for Asthma
explores asthma both as incidence of dysfunctional airway smooth muscle and as a
disorder of the immune system
examines the role of monoclonal antibodies in allergy and asthma
describes functions and pharmacokinetic profiles